For example, hyperthermia at 42°C was shown to suppress the gene and protein expression of VEGF in human fibrosarcoma HT-1080 cells, and the level of VEGF in sera from cancer patients was significantly diminished 2–3 weeks after treatment with whole-body hyperthermia at 42°C (24). The gene discussed is VEGFA; the disease is cancer.